Renewable fuels producer Gevo (NASDAQ:GEVO) missed Wall Street’s revenue expectations in Q1 CY2026, but sales rose 47.5% year on year to $42.95 million. Its GAAP loss of $0.09 per share was ...
The formulation development outsourcing market offers opportunities driven by increasing pharmaceutical R&D complexity, ...
May 11, 2026 expert reaction to study on association between GLP-1 use and breast cancer survival and recurrence . A study published in Nature Medicine looks at an association bet ...
This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF), through subsidiary GlucaPharm Inc., is advancing ...
Leadership students from Jean Augustine Secondary School empowered more than 100 Grade 8 students at Eldorado Public School ...
MarketBeat on MSN
Coherus Oncology Q1 earnings call highlights
Coherus Oncology (NASDAQ:CHRS) said it expects revenue growth for its nasopharyngeal cancer drug LOQTORZI to build through ...
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results